In its new guidance (PDF), health technology assessment (HTA) agency NICE notes that, at the moment, patients with chronic ITP who do not respond to or cannot tolerate TPO-RA drugs are treated ...

Background: To analyse available evidence on the efficacy and safety of anti-TNFα drugs (infliximab, etanercept and adalimumab) for treating rheumatoid arthritis (RA). Methods: We searched ...

The FDA has accepted Novartis’ supplemental New Drug Application (sNDA ... is an oral thrombopoietin receptor agonist (TPO-RA) that is already approved for SAA in the refractory setting for ...

Disappointingly, a third drug also tested in the study failed to show additive efficacy in RA when combined with tofacitinib ...

Some biologic drugs for RA come in shots, while others are given as IV infusions. If you get shots, your doctor or nurse can give you injections at the doctor's office. They can teach you how to ...

The US Food and Drug Administration (FDA ... is a thrombopoietin receptor agonist (TPO-RA) that does not compete with thrombopoietin (TPO) for receptor binding. It functions by stimulating ...